A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/513 (2006.01) A61K 31/519 (2006.01) A61K 33/24 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01)
Patent
CA 2715348
The invention provides a method of treatment of metastatic colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with bevacizumab (Avastin®) and optionally, with 5-FU and leucovorin in a variety of treatment regimens. The invention also provides a use of picoplatin in conjunction with bevacizumab and, optionally, 5-FU and leucovorin, for the treatment of metastatic colorectal cancer.
L'invention porte sur un procédé de traitement d'un cancer colorectal métastatique par administration de picoplatine, médicament anti-cancereux à base de platine, conjointement à du bévacizumab (Avastin®) et facultativement, à du 5-FU et de la leucovorinem, dans une variété de régimes de traitement. L'invention porte également sur lutilisation du picoplatine conjointement à du bévacizumab et, facultativement, à du 5-FU et la leucovorine, pour le traitement d'un cancer colorectal métastatique.
Karlin David A.
Martell Ronald A.
Poniard Pharmaceuticals Inc.
Ridout & Maybee Llp
LandOfFree
Use of picoplatin and bevacizumab to treat colorectal cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of picoplatin and bevacizumab to treat colorectal cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of picoplatin and bevacizumab to treat colorectal cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1828356